683 Capital Management »

Moonlake Immunot shares owned by 683 Capital Management

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.9M 297k 13.18

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Moonlake Immunot

BVF
Deep Track Capital
Cormorant Asset Management
Logos Global Management
Balyasny Asset Management
Jane Street
Adage Capital Partners GP
Susquehanna International
Vivo Capital
Point72 Asset Management
FMR
Nuveen
Hrt Financial
Citadel Advisors
Leucadia National Corporation

View all funds holding Moonlake Immunot